About
Wondfo, officially known as Guangzhou Wondfo Biotech Co., Ltd., is a prominent biotechnology company based in Guangzhou, China. Founded in 1992, Wondfo focuses on the research, development, manufacturing, and sales of in vitro diagnostic (IVD) products. The company is recognized as a high-tech enterprise and was the first public company in China's point-of-care testing sector, listed on the Shenzhen Stock Exchange in 2015. Wondfo operates nine technology platforms that support a wide range of diagnostic needs, offering over 100 products. These include rapid diagnostic tests for infectious diseases, chronic disease markers, and veterinary diagnostics. The company serves healthcare providers globally, reaching over 150 countries, with specialized subsidiaries like Wondfo USA catering to the North American market. Wondfo is committed to delivering reliable diagnostic solutions and has achieved several milestones, including the development of COVID-19 diagnostic products and receiving WHO prequalification for its HIV rapid test.
Technologies
Keywords
Company Information
-
Employees 3200
-
Founded 1992
-
Annual Revenue $379972000
Location
Guangzhou, Guangdong, China
